Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Microproteinuria: Indicator To Monitor CNI-Related Nephrotoxicity In Liver Transplant Recipients?
Deterioration of renal function with CNI therapy has been widely reported in liver transplant recipients. Microproteinuria has been used to monitor the early changes of nephropathy in renal disease or cardiovascular events. However, whether microproteinuria could be used as an early and sensitive indicator to monitor CNI-related nephrotoxicity in liver transplant recipients has not been unequivocally addressed.

Shire Announces Study Results Of The Effects Of INTUNIV™ Extended Release On Secondary Measures In Children With ADHD And Oppositional Symptoms
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced new findings on INTUNIV (guanfacine) extended release, a selective alpha-2A-agonist, at a major psychiatric meeting. This randomized placebo controlled trial met its primary objective, which was to evaluate the effects of INTUNIV on oppositional symptoms in children aged 6 to 12 years with a diagnosis of ADHD and the presence of oppositional symptoms. The data presented today on this investigational compound reviewed secondary efficacy measures from three different rating scales.
News of the day
Lowering Your Blood Pressure Can Be As Easy As Watching What You Eat
According to the National Institutes of Health (NIH), about two-thirds of people over the age of 65 have high blood pressure. What"s more, they report that if you haven"t had it by the time you reach age 55, there is a 90 percent chance you will end up with it during your lifetime. It is something that almost all of us will encounter in our lifetime. But the good news is that watching what you eat can go a long way toward helping you avoid high blood pressure and get the problem under control.
Cardiovascular

Sixth International Congress On Peer Review And Biomedical Publication

When September 10 - 12, 2009 Where Vancouver, BC, Canada New research will be presented about peer review and other processes to evaluate and disseminate medical and scientific research and other information during the conference. Every four years, editors, publishers and researchers representing the leading medical and scientific institutions and journals from around the world meet with the goal to improve the quality and credibility of biomedical peer review and publication. Topics Include: Authorship and Ghost Writing Conflicts of Interest Editorial Decisions and Peer Review Ethical Concerns Publication Bias "Spin" on Study Results Clinical Trial Registration Quality of Biomedical Publication Postpublication Concerns Complete program information available at http://www.jama-peer.org. Free Registration for Credentialed Journalists: Register online at http://www.jamamedia.org on the Events page or onsite. Special hotel room rates available at the Westin Bayshore Hotel, Vancouver: http://www.ama-assn.org/public/peer/hotel.html. Journal of the Amercian Medical Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009